Supplements growth positions pharmacy for gains

HYDERABAD, India — The U.S. market for herbal and dietary supplements is entering a period of sustained growth, with implications for retail pharmacy as consumers increasingly turn to self-care and preventive health solutions.

According to new data from Mordor Intelligence, the global herbal supplements market is projected to reach $75.41 billion by 2031, with a compound annual growth rate of 5.75%. North America, led by the United States, remains the dominant market, supported by high consumer awareness, a strong retail infrastructure and rising demand for wellness products.

For pharmacy operators, the trend underscores a broader shift in patient behavior. Consumers are seeking alternatives to traditional prescription pathways, particularly for immune support, stress management and maintenance of chronic conditions. This is driving increased traffic and basket expansion in front-end categories, including vitamins, minerals and supplements.

A key driver is the shift toward clean-label and plant-based formulations. U.S. consumers are placing greater emphasis on transparency, third-party certification, and ingredient sourcing, prompting suppliers to invest in traceability and quality assurance.

At the same time, format innovation is reshaping how supplements are merchandised and consumed. Gummies, chewables, and liquid delivery systems are gaining traction, particularly among younger demographics and adherence-sensitive populations. These formats align closely with pharmacy strategies to improve compliance and patient engagement.

Digital transformation is also accelerating category growth. E-commerce, subscription models, and personalized nutrition platforms are expanding access, reinforcing loyalty, and creating new competitive dynamics for brick-and-mortar pharmacy chains.

The aging U.S. population remains a foundational driver of growth. As more consumers prioritize preventive health, demand for supplements targeting cognitive function, joint health, and immune support continues to rise. This aligns with pharmacy’s evolving role as a frontline healthcare destination, particularly amid persistent provider shortages.

However, the category faces operational and regulatory challenges. Increasing scrutiny of quality standards and labeling is raising compliance costs, favoring larger, vertically integrated players with stronger supply chain control.

For chain drug retailers, the takeaway is clear: supplements are no longer a peripheral category. They are central to front-end strategy, clinical positioning, and long-term growth in a healthcare environment increasingly defined by prevention and consumer choice.

For a full breakdown of market size, segmentation data, and competitive intelligence on the herbal supplements industry, read details of the Mordor Intelligence report, click here.